Skip to main content
Erschienen in: Neurocritical Care 1/2021

18.06.2020 | Original Work

Low Triglyceride Levels are Associated with Unfavorable Outcomes in Patients with Spontaneous Intracerebral Hemorrhage

verfasst von: Qian Liu, Wenjuan Zhao, Yonghong Xing, Yan Hong, Guanen Zhou

Erschienen in: Neurocritical Care | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Background and Aims

The relationship between serum lipid level and clinical outcome after spontaneous intracerebral hemorrhage (ICH) remains controversial. We sought to evaluate the association of serum lipid levels with clinical outcomes in patients with ICH.

Methods

Data on consecutive patients hospitalized with spontaneous ICH were prospectively collected from May 2005 to May 2018 and retrospectively analyzed. Following clinical and demographic data, age and gender, risk factors, serum lipid levels [total cholesterol, triglycerides (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) cholesterol] and the outcomes were analyzed.

Results

A total of 1451 patients with ICH (mean age, 60.41 ± 12.3 years; 32.6% women) was evaluated. Although admission TG levels were associated with the outcomes at hospital discharge and 3 months in initial univariate analyses, the former association did not retain its statistical significance in multivariate logistic regression analyses adjusting for potential confounders. However, lower admission TG levels were independently associated (p = 0.045) with a higher likelihood of 12-month unfavorable outcomes (odds ratio 0.91, 95% confidence interval 0.83–0.99) in multivariate logistic regression models.

Conclusions

Low TG levels at hospital admission were an independent predictor for unfavorable long-term outcomes in patients with spontaneous ICH. The exact mechanisms of the association need further investigations.
Literatur
1.
Zurück zum Zitat Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1:e259–81.CrossRef Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1:e259–81.CrossRef
2.
Zurück zum Zitat Jolink WM, Klijn CJ, Brouwers PJ, Kappelle LJ, Vaartjes I. Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage. Neurology. 2015;85:1318–24.CrossRef Jolink WM, Klijn CJ, Brouwers PJ, Kappelle LJ, Vaartjes I. Time trends in incidence, case fatality, and mortality of intracerebral hemorrhage. Neurology. 2015;85:1318–24.CrossRef
3.
Zurück zum Zitat Mozaffarian D, Benjamin EJ, Writing Group M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–360.PubMed Mozaffarian D, Benjamin EJ, Writing Group M, et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation. 2016;133:e38–360.PubMed
4.
Zurück zum Zitat Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA. 2008;300:2142–52.CrossRef Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA. 2008;300:2142–52.CrossRef
5.
Zurück zum Zitat Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34:623–31.CrossRef Shahar E, Chambless LE, Rosamond WD, et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34:623–31.CrossRef
6.
Zurück zum Zitat Navar AM. The evolving story of triglycerides and coronary heart disease risk. JAMA. 2019;321:347–9.CrossRef Navar AM. The evolving story of triglycerides and coronary heart disease risk. JAMA. 2019;321:347–9.CrossRef
7.
Zurück zum Zitat Wieberdink RG, Poels MM, Vernooij MW, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31:2982–9.CrossRef Wieberdink RG, Poels MM, Vernooij MW, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31:2982–9.CrossRef
8.
Zurück zum Zitat Lei C, Lin S, Wu B, Li H, Liu M, You C. Lipid levels are regionally associated with cerebral microbleeds in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2014;23:1195–8.CrossRef Lei C, Lin S, Wu B, Li H, Liu M, You C. Lipid levels are regionally associated with cerebral microbleeds in patients with intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2014;23:1195–8.CrossRef
9.
Zurück zum Zitat Roquer J, Rodriguez Campello A, Gomis M, Ois A, Munteis E, Bohm P. Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology. 2005;65:1198–202.CrossRef Roquer J, Rodriguez Campello A, Gomis M, Ois A, Munteis E, Bohm P. Serum lipid levels and in-hospital mortality in patients with intracerebral hemorrhage. Neurology. 2005;65:1198–202.CrossRef
10.
Zurück zum Zitat Zhou JF, Wang JY, Luo YE, Chen HH. Influence of hypertension, lipometabolism disorders, obesity and other lifestyles on spontaneous intracerebral hemorrhage. Biomed Environ Sci. 2003;16:295–303.PubMed Zhou JF, Wang JY, Luo YE, Chen HH. Influence of hypertension, lipometabolism disorders, obesity and other lifestyles on spontaneous intracerebral hemorrhage. Biomed Environ Sci. 2003;16:295–303.PubMed
11.
Zurück zum Zitat Zia E, Pessah-Rasmussen H, Khan FA, et al. Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. Cerebrovasc Dis. 2006;21:18–25.CrossRef Zia E, Pessah-Rasmussen H, Khan FA, et al. Risk factors for primary intracerebral hemorrhage: a population-based nested case-control study. Cerebrovasc Dis. 2006;21:18–25.CrossRef
12.
Zurück zum Zitat Akoudad S, Ikram MA, Portegies ML, et al. Genetic loci for serum lipid fractions and intracerebral hemorrhage. Atherosclerosis. 2016;246:287–92.CrossRef Akoudad S, Ikram MA, Portegies ML, et al. Genetic loci for serum lipid fractions and intracerebral hemorrhage. Atherosclerosis. 2016;246:287–92.CrossRef
13.
Zurück zum Zitat Chang JJ, Katsanos AH, Khorchid Y, et al. Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage. Atherosclerosis. 2018;269:14–20.CrossRef Chang JJ, Katsanos AH, Khorchid Y, et al. Higher low-density lipoprotein cholesterol levels are associated with decreased mortality in patients with intracerebral hemorrhage. Atherosclerosis. 2018;269:14–20.CrossRef
14.
Zurück zum Zitat Messe SR, Pervez MA, Smith EE, et al. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. Stroke. 2013;44:1354–9.CrossRef Messe SR, Pervez MA, Smith EE, et al. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. Stroke. 2013;44:1354–9.CrossRef
15.
Zurück zum Zitat Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541–53.PubMedPubMedCentral Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541–53.PubMedPubMedCentral
16.
Zurück zum Zitat Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38:1091–6.CrossRef Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38:1091–6.CrossRef
17.
Zurück zum Zitat Wang X, Dong Y, Qi X, Huang C, Hou L. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke. 2013;44:1833–9.CrossRef Wang X, Dong Y, Qi X, Huang C, Hou L. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke. 2013;44:1833–9.CrossRef
18.
Zurück zum Zitat Xie L, Wu W, Chen J, et al. Cholesterol levels and hemorrhagic stroke risk in East Asian versus non-East Asian populations: a systematic review and meta-analysis. Neurologist. 2017;22:107–15.CrossRef Xie L, Wu W, Chen J, et al. Cholesterol levels and hemorrhagic stroke risk in East Asian versus non-East Asian populations: a systematic review and meta-analysis. Neurologist. 2017;22:107–15.CrossRef
19.
Zurück zum Zitat Sturgeon JD, Folsom AR, Longstreth WT Jr, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38:2718–25.CrossRef Sturgeon JD, Folsom AR, Longstreth WT Jr, Shahar E, Rosamond WD, Cushman M. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38:2718–25.CrossRef
20.
Zurück zum Zitat Bonaventure A, Kurth T, Pico F, et al. Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: the Three-City Study. Atherosclerosis. 2010;210:243–8.CrossRef Bonaventure A, Kurth T, Pico F, et al. Triglycerides and risk of hemorrhagic stroke vs. ischemic vascular events: the Three-City Study. Atherosclerosis. 2010;210:243–8.CrossRef
21.
Zurück zum Zitat Romero JR, Preis SR, Beiser A, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke. 2014;45:1492–4.CrossRef Romero JR, Preis SR, Beiser A, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke. 2014;45:1492–4.CrossRef
22.
Zurück zum Zitat Noda H, Iso H, Irie F, et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation. 2009;119:2136–45.CrossRef Noda H, Iso H, Irie F, et al. Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study. Circulation. 2009;119:2136–45.CrossRef
23.
Zurück zum Zitat Wang DN, Hou XW, Yang BW, Lin Y, Shi JP, Wang N. Quantity of cerebral microbleeds, antiplatelet therapy, and intracerebral hemorrhage outcomes: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2015;24:2728–37.CrossRef Wang DN, Hou XW, Yang BW, Lin Y, Shi JP, Wang N. Quantity of cerebral microbleeds, antiplatelet therapy, and intracerebral hemorrhage outcomes: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2015;24:2728–37.CrossRef
24.
Zurück zum Zitat Lin WM, Yang TY, Weng HH, et al. Brain microbleeds: distribution and influence on hematoma and perihematomal edema in patients with primary intracerebral hemorrhage. Neuroradiol J. 2013;26:184–90.CrossRef Lin WM, Yang TY, Weng HH, et al. Brain microbleeds: distribution and influence on hematoma and perihematomal edema in patients with primary intracerebral hemorrhage. Neuroradiol J. 2013;26:184–90.CrossRef
25.
Zurück zum Zitat Konishi M, Iso H, Komachi Y, et al. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study. Stroke. 1993;24:954–64.CrossRef Konishi M, Iso H, Komachi Y, et al. Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study. Stroke. 1993;24:954–64.CrossRef
26.
Zurück zum Zitat Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol. 1996;16:1333–9.CrossRef Silveira A, Karpe F, Johnsson H, Bauer KA, Hamsten A. In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway. Arterioscler Thromb Vasc Biol. 1996;16:1333–9.CrossRef
27.
Zurück zum Zitat Moor E, Silveira A, van’t Hooft F, et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol. 1995;15:655–64.CrossRef Moor E, Silveira A, van’t Hooft F, et al. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype. Arterioscler Thromb Vasc Biol. 1995;15:655–64.CrossRef
28.
Zurück zum Zitat Ghaddar HM, Folsom AR, Aleksic N, et al. Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation. 1998;98:2815–21.CrossRef Ghaddar HM, Folsom AR, Aleksic N, et al. Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation. 1998;98:2815–21.CrossRef
29.
Zurück zum Zitat Priglinger M, Arima H, Anderson C, Krause M, Investigators I. No relationship of lipid-lowering agents to hematoma growth: pooled analysis of the intensive blood pressure reduction in acute cerebral hemorrhage trials studies. Stroke. 2015;46:857–9.CrossRef Priglinger M, Arima H, Anderson C, Krause M, Investigators I. No relationship of lipid-lowering agents to hematoma growth: pooled analysis of the intensive blood pressure reduction in acute cerebral hemorrhage trials studies. Stroke. 2015;46:857–9.CrossRef
30.
Zurück zum Zitat Mustanoja S, Strbian D, Putaala J, et al. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage. Stroke. 2013;44:2330–2.CrossRef Mustanoja S, Strbian D, Putaala J, et al. Association of prestroke statin use and lipid levels with outcome of intracerebral hemorrhage. Stroke. 2013;44:2330–2.CrossRef
Metadaten
Titel
Low Triglyceride Levels are Associated with Unfavorable Outcomes in Patients with Spontaneous Intracerebral Hemorrhage
verfasst von
Qian Liu
Wenjuan Zhao
Yonghong Xing
Yan Hong
Guanen Zhou
Publikationsdatum
18.06.2020
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe 1/2021
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-020-01023-0

Weitere Artikel der Ausgabe 1/2021

Neurocritical Care 1/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.